期刊文献+

胰岛素诱导基因-2启动子荧光素酶报告基因重组质粒的构建与鉴定

Construction and identification of recombinant plasmid containing insulin induced gene-2 promoter luciferase reporter
原文传递
导出
摘要 目的构建胰岛素诱导基因-2(Insulin induced gene-2,Insig-2)启动子荧光素酶报告基因重组质粒,并检测其转录活性。方法从人基因组DNA中扩增Insig-2基因转录起始位点上游1 389 bp的启动子片段,插入pGL3-basic质粒中,构建重组质粒pGL3-Insig-2,将其与内参质粒pRL-TK瞬时共转染HEK293、HepG2和3T3-L1细胞,采用双荧光素酶法检测Insig-2启动子活性。结果重组质粒pGL3-Insig-2经双酶切和DNA测序,证实构建正确;pGL3-Insig-2质粒在HEK293、HepG2和3T3-L1细胞中均具有启动子活性,分别为阴性对照组(pGL3-basic空载体)的28、40和214倍、阳性对照组(pGL3-SV40)的2.6、5.5和30倍,呈现出强启动子活性。结论成功构建了Insig-2基因启动子荧光素酶报告基因重组质粒,为后续Insig-2基因的深入研究奠定了基础。 Objective To construct the recombinant plasmid containing human insulin induced gene-2(Insig-2) promoter luciferase reporter,and determine its transcriptional activity.Methods The promoter fragment at a length of 1 389 bp upstream at transcription site of insig-2 gene was amplified by PCR from human genomic DNA and inserted into vector pGL3-basic.The constructed recombinant plasmid pGL3-Insig-2 and internal reference plasmid pRL-TK were transiently co-transfected to HEK293,HepG2 and 3T3-L1 cells,and determined for Insig-2 promoter activity by dual-luciferase reporter assay.Results Restriction analysis and sequencing proved that recombinant plasmid pGL3-Insig-2 was constructed correctly.The recombinant plasmid showed promoter activity in HEK293,HepG2 and 3T3-L1 cells,which were 28,40 and 214 times of those in negative control group(empty vector pGL3-basic) and 2.6,5.5 and 30 times of those in positive control group(pGL3-SV40),respectively.Conclusion Recombinant plasmid containing Insig-2 promoter luciferase reporter was successfully constructed,which laid a foundation of further study on the gene.
出处 《中国生物制品学杂志》 CAS CSCD 2013年第4期465-468,共4页 Chinese Journal of Biologicals
基金 国家自然科学基金资助项目(30600812)
关键词 胰岛素诱导基因-2 启动子 荧光素酶 报告基因 Insulin induced gene-2(Insig-2) Promoter Luciferase Reporter gene
  • 相关文献

参考文献11

  • 1KimJS, Lee HC, Choi BK, et 01. Impact of metabolic syndrome on in-stent restenosis and clinical outcomes after percutaneous coronary stent implanfion[xJ. Diabetes Res Clin Pract, 2010, 88 (3): e38-e4l.
  • 2Yabe D, Brown MS, GoldsteinJL Insig-2, a second endoplasmic reticulum protein that bind SCAP and blocks of sterol regulatory element-binding proteins[J]. Proc Nat! Acad Sci USA, 2002, 99 (20): 12753-12758.
  • 3Ka SO, Kim KA, Kwon KB, et 01. Silibinin attenuates adipo?genesis in 3T3-L1 preadipocytes through a potential upregulation of the insig pathway[Jl. IntJ Mol Med, 2009, 23 (5): 633-637.
  • 4Xie YH, Mo ZH, Chen K, et 01. Effect of different glucose concentrations on the expressions of insig-I and insig-2 mRNA during the differentiation of 3T3-Ll cells[X]. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2008, 33 (3): 238-244.
  • 5Krapivner S, Popov S, Chernogubova E, et 01. Insulin-induced gene 2 involvement in human adipocyte metabolism and body weight regulation[J].J Clin Endocrinol Metab, 2008, 93 (5): 1995-200l.
  • 6Skelding KA, Gerhard GS, Vlachos H, et 01. Association of an INSIG2 obesity allele with cardiovascular phenotypes is gender and age dependent[J]. BMC Cardiovascular Disorders, 2010, 10 (1): 46-52.
  • 7Liu GF, Zhu HD, Dong YB, et 01. Influence of common variants in FTO and near INSIG2 and MC4R on growth curves for adiposity in African- and European-American youth[J]. EurJ Epidemiol, 2011, 26( 6): 463-473.
  • 8BresslerJ, Fornage M, Hanis CL, et 01. The INSIG2 rs7566605 genetic variant does not playa major role in obesity in a sample of 24,722 individuals from four cohorts[n BMC Med Genet, 2009, W( 1): 56-64.
  • 9Fernondez-Alvarez A, Soledad Alvarez M, Cucarella C, et 01. Characterization of the human insulin-induced gene 2 (INSIG2) promoter: the role of Ets-binding motifs[J].J Bioi Chern, 2010, 285 (16): 11765-11774.
  • 10Lee S, Lee DK, Choi E, et 01. Identification of a function vitamin D response element in the murine Insig-2 promoter and its potential role in the differentiation of 3T3-Ll preadipocytes[J]. Mol Endocrinol, 2005, 19 (2): 399-408.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部